C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases

Rongbao Gao(National Institute for Viral Disease Control and Prevention), Yuelong Shu(Sun Yat-sen University), Tian Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Hong(National Health and Family Planning Commission), Ye Zhang(Shandong University), Lijie Wang(Inner Mongolia Agricultural University)
EBioMedicine
July 13, 2017
10.1016/j.ebiom.2017.07.010
Cited by 32

Related Papers

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
|New England Journal of Medicine|2013|698
Global circulation patterns of seasonal influenza viruses vary with antigenic drift
|Nature|2015|664
Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study
|The Lancet|2014|663
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
|Nature Communications|2014|422